Hyperbaric oxygen therapy (HBOT) stands at the forefront of functional, anti-aging medical innovation. Originally used to treat conditions such as carbon monoxide poisoning and air or gas embolism, this modality is now emerging as a promising therapeutic option for a wide variety of health conditions. HBOT’s versatility makes it ideal for tailored protocols based on a patient’s unique needs — especially beneficial for women who have evolving healthcare priorities across their lifespans.
By leveraging oxygen’s restorative properties to offer drug-free healing, HBOT activates regenerative physiological processes that optimize female health and well-being. Specific applications currently under investigation include supporting hormonal balance, reproductive health, and weight management, among many other potential uses. HBOT protocols are also being developed to target autoimmune disorders, metabolic conditions, and age-related decline in women.
With its ability to stimulate the body’s innate healing capacities, HBOT represents the future of functional medicine – harnessing natural healing pathways through the power of oxygen to meet women’s health needs throughout all stages of life.
Last weekend, A4M hosted the largest anti-aging medicine event ever, gathering over 5,500 guests, 120 globally renowned speakers and educators, and 400 market-shaping companies. Delivering four full days of cutting-edge science, the latest research, and meaningful, practical education, LongevityFest 2022 marked a pivotal point in A4M’s history and that of the specialty itself.
The conference was packed with noteworthy moments: from a keynote address by the celebrated innovator Peter Diamandis, MD, to the launch of new products from industry leaders like Precision Analytical and Quicksilver Scientific. But most exciting was seeing so many people coming together to celebrate this growing field and its future.
While there were too many unforgettable happenings to list, this blog highlights some of the most noteworthy educational takeaways presented by our star-studded panel of experts at LongevityFest 2022.
Characterized by the progressive loss of physiological capacity resulting in impaired functioning and susceptibility to diseases, the biological aging process at a cellular level has two key hallmark elements: telomere length (TL) shortening and cellular senescence. A variety of therapeutic methods aimed at reversing or slowing down this process continues to be investigated while a novel treatment shows promise – a specialized form of oxygen therapy that may be able to reverse the aforementioned biological markers of aging.
In a new small study published in the Journal of Aging, researchers present potential breakthrough findings. Per their results, hyperbaric oxygen therapy (HBOT) may be an effective method for delaying or even reversing cellular degeneration as it was shown to lengthen telomeres and decrease levels of senescent cells, potentially helping prevent age-related illnesses such as cancer, diabetes, and dementia.